Cargando…

Development and Validation of a Novel Mitochondrion and Ferroptosis-Related Long Non-Coding RNA Prognostic Signature in Hepatocellular Carcinoma

Mitochondrion and ferroptosis are related to tumorigenesis and tumor progression of hepatocellular carcinoma (HCC). Therefore, this study focused on exploring the participation of lncRNAs in mitochondrial dysfunction and ferroptosis using public datasets from The Cancer Genome Atlas (TCGA) database....

Descripción completa

Detalles Bibliográficos
Autores principales: Xia, Wuzheng, Zeng, Cong, Zheng, Zehao, Huang, Chunwang, Zhou, Yu, Bai, Lan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413087/
https://www.ncbi.nlm.nih.gov/pubmed/36036006
http://dx.doi.org/10.3389/fcell.2022.844759
_version_ 1784775650203140096
author Xia, Wuzheng
Zeng, Cong
Zheng, Zehao
Huang, Chunwang
Zhou, Yu
Bai, Lan
author_facet Xia, Wuzheng
Zeng, Cong
Zheng, Zehao
Huang, Chunwang
Zhou, Yu
Bai, Lan
author_sort Xia, Wuzheng
collection PubMed
description Mitochondrion and ferroptosis are related to tumorigenesis and tumor progression of hepatocellular carcinoma (HCC). Therefore, this study focused on exploring the participation of lncRNAs in mitochondrial dysfunction and ferroptosis using public datasets from The Cancer Genome Atlas (TCGA) database. We identified the mitochondrion- and ferroptosis-related lncRNAs by Pearson’s analysis and lasso-Cox regression. Moreover, real-time quantitative reverse transcription PCR (RT-qPCR) was utilized to further confirm the abnormal expression of these lncRNAs. Based on eight lncRNAs, the MF-related lncRNA prognostic signature (LPS) with outstanding stratification ability and prognostic prediction capability was constructed. In addition, functional enrichment analysis and immune cell infiltration analysis were performed to explore the possible functions of lncRNAs and their impact on the tumor microenvironment. The pathways related to G2M checkpoint and MYC were activated, and the infiltration ratio of regulatory T cells and M0 and M2 macrophages was higher in the high-risk group. In conclusion, these lncRNAs may affect mitochondria functions, ferroptosis, and immune cell infiltration in HCC through specific pathways, which may provide valuable insight into the progression and therapies of HCC.
format Online
Article
Text
id pubmed-9413087
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-94130872022-08-27 Development and Validation of a Novel Mitochondrion and Ferroptosis-Related Long Non-Coding RNA Prognostic Signature in Hepatocellular Carcinoma Xia, Wuzheng Zeng, Cong Zheng, Zehao Huang, Chunwang Zhou, Yu Bai, Lan Front Cell Dev Biol Cell and Developmental Biology Mitochondrion and ferroptosis are related to tumorigenesis and tumor progression of hepatocellular carcinoma (HCC). Therefore, this study focused on exploring the participation of lncRNAs in mitochondrial dysfunction and ferroptosis using public datasets from The Cancer Genome Atlas (TCGA) database. We identified the mitochondrion- and ferroptosis-related lncRNAs by Pearson’s analysis and lasso-Cox regression. Moreover, real-time quantitative reverse transcription PCR (RT-qPCR) was utilized to further confirm the abnormal expression of these lncRNAs. Based on eight lncRNAs, the MF-related lncRNA prognostic signature (LPS) with outstanding stratification ability and prognostic prediction capability was constructed. In addition, functional enrichment analysis and immune cell infiltration analysis were performed to explore the possible functions of lncRNAs and their impact on the tumor microenvironment. The pathways related to G2M checkpoint and MYC were activated, and the infiltration ratio of regulatory T cells and M0 and M2 macrophages was higher in the high-risk group. In conclusion, these lncRNAs may affect mitochondria functions, ferroptosis, and immune cell infiltration in HCC through specific pathways, which may provide valuable insight into the progression and therapies of HCC. Frontiers Media S.A. 2022-08-12 /pmc/articles/PMC9413087/ /pubmed/36036006 http://dx.doi.org/10.3389/fcell.2022.844759 Text en Copyright © 2022 Xia, Zeng, Zheng, Huang, Zhou and Bai. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cell and Developmental Biology
Xia, Wuzheng
Zeng, Cong
Zheng, Zehao
Huang, Chunwang
Zhou, Yu
Bai, Lan
Development and Validation of a Novel Mitochondrion and Ferroptosis-Related Long Non-Coding RNA Prognostic Signature in Hepatocellular Carcinoma
title Development and Validation of a Novel Mitochondrion and Ferroptosis-Related Long Non-Coding RNA Prognostic Signature in Hepatocellular Carcinoma
title_full Development and Validation of a Novel Mitochondrion and Ferroptosis-Related Long Non-Coding RNA Prognostic Signature in Hepatocellular Carcinoma
title_fullStr Development and Validation of a Novel Mitochondrion and Ferroptosis-Related Long Non-Coding RNA Prognostic Signature in Hepatocellular Carcinoma
title_full_unstemmed Development and Validation of a Novel Mitochondrion and Ferroptosis-Related Long Non-Coding RNA Prognostic Signature in Hepatocellular Carcinoma
title_short Development and Validation of a Novel Mitochondrion and Ferroptosis-Related Long Non-Coding RNA Prognostic Signature in Hepatocellular Carcinoma
title_sort development and validation of a novel mitochondrion and ferroptosis-related long non-coding rna prognostic signature in hepatocellular carcinoma
topic Cell and Developmental Biology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413087/
https://www.ncbi.nlm.nih.gov/pubmed/36036006
http://dx.doi.org/10.3389/fcell.2022.844759
work_keys_str_mv AT xiawuzheng developmentandvalidationofanovelmitochondrionandferroptosisrelatedlongnoncodingrnaprognosticsignatureinhepatocellularcarcinoma
AT zengcong developmentandvalidationofanovelmitochondrionandferroptosisrelatedlongnoncodingrnaprognosticsignatureinhepatocellularcarcinoma
AT zhengzehao developmentandvalidationofanovelmitochondrionandferroptosisrelatedlongnoncodingrnaprognosticsignatureinhepatocellularcarcinoma
AT huangchunwang developmentandvalidationofanovelmitochondrionandferroptosisrelatedlongnoncodingrnaprognosticsignatureinhepatocellularcarcinoma
AT zhouyu developmentandvalidationofanovelmitochondrionandferroptosisrelatedlongnoncodingrnaprognosticsignatureinhepatocellularcarcinoma
AT bailan developmentandvalidationofanovelmitochondrionandferroptosisrelatedlongnoncodingrnaprognosticsignatureinhepatocellularcarcinoma